Skip to main content
Skip to section navigation
Skip to footer
About
Overview
Management Team
Board of Directors
Pipeline
Overview
TRV045
TRV250
TRV734
Products
OLINVYK® (oliceridine) injection
Medical Affairs
Investigator-Initiated Trials
Contact Medical Information
Publications
Investors
Overview
Press Releases
Events & Presentations
Financial Info
Stock Info
Resources
Governance
Careers
Contact
Contact Medical Information
Whistleblower Hotline
IR Calendar
Investors
Investors
Overview
Press Releases
Events & Presentations
IR Calendar
Presentations
Financial Info
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Stock Info
Quote
Analyst Coverage
IRS Form 8937
Resources
Email Alerts
Contacts
FAQ
Governance
Overview
Management Team
Board of Directors
Governance Documents
Fourth Quarter & Full Year 2022 Financial Results
Mar 30, 2023 8:00 am EDT
Webcast
Audio
Email Alerts
Contacts
RSS News Feed
Sitemap